EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota

Yuxin Jiang, Huan Xie, Hao Zhang, Jinsong Zhang, Yanfei Yu, Yanan Chen, Hao Wang, Chenhuan Lai, Qiang Yong

Antioxidants · 03.11.2026 · 15 (11) · 1425

DOI: 10.3390/antiox15111425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 03.11.2026. Verfasst von Yuxin Jiang und 8 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Jiangsu Provincial Young Science and Technology Talent Support Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal epithelial barrier dysfunction, a major consequence of inflammatory and oxidative stress, contributes to enteric disorder progression. Salvianolic acid B (SAB), a prominent water-soluble phenolic compound in Salvia miltiorrhiza, shows intestinal protective potential, but the underlying mechanisms remain unclear.

Methods

This study investigated the protective effects of SAB on intestinal barrier function using a lipopolysaccharide (LPS)-challenged piglet model and LPS-stimulated IPEC-J2 cells.

Results

SAB alleviated LPS-induced intestinal injury, evidenced by reduced plasma diamine oxidase and D-lactate levels, improved intestinal morphology, decreased pro-inflammatory cytokines, and enhanced antioxidant capacity. SAB also strengthened intestinal barrier integrity by increasing goblet cell number and mucin 2 levels and upregulating tight junction protein expression. Moreover, SAB restored epithelial proliferation–apoptosis balance and increased PI3K/AKT/mTOR phosphorylation. Molecular docking and molecular dynamics simulations predicted a stable SAB–PI3Kα/p110α interaction, whereas LY294002 treatment attenuated SAB-mediated restoration of epithelial renewal and barrier integrity in LPS-treated IPEC-J2 cells. SAB also altered the jejunal microbial composition, including higher relative abundance of Streptococcus and lower relative abundance of Escherichia-Shigella, together with increased jejunal acetate and lactate concentrations.

Conclusions

SAB alleviates inflammation-associated intestinal barrier dysfunction by restoring epithelial proliferation–apoptosis balance and regulating the microbiota–metabolite profile.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Jiangsu Provincial Young Science and Technology Talent Support Program

Zitieren

APA

Jiang, Y., Xie, H., Zhang, H., Zhang, J., Yu, Y., Chen, Y., Wang, H., Lai, C., & Yong, Q. (2026). Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota. Antioxidants, 15(11), 1425. https://doi.org/10.3390/antiox15111425

Vancouver

Jiang Y, Xie H, Zhang H, Zhang J, Yu Y, Chen Y, et al. Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota. Antioxidants. 2026;15(11):1425. doi:10.3390/antiox15111425

BibTeX
@article{Jiang2026,
  author = {Jiang, Yuxin and Xie, Huan and Zhang, Hao and Zhang, Jinsong and Yu, Yanfei and Chen, Yanan and Wang, Hao and Lai, Chenhuan and Yong, Qiang},
  title = {Salvianolic Acid B Alleviates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Restoring Epithelial Proliferation–Apoptosis Balance and Modulating the Gut Microbiota},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1425},
  doi = {10.3390/antiox15111425}
}
Kostenlos starten →